Tilray Brands has secured an exclusive multi-year licensing agreement to produce, market and distribute Carlsberg, Carlsberg Elephant, 1664 and Kronenbourg 1664 Blanc beers across the United States from January 1, 2027. The deal leverages Tilray’s existing U.S. brewing operations and brand development capabilities. It covers several Carlsberg-branded products and aims to enhance market share in the world’s second-largest beer market. This strategic partnership aligns with Tilray’s growth focus on beverage operations.

Amplify Alternative Harvest ETF (MJ) holds a 12.38% position in Tilray Brands, making this licensing agreement a key driver for the fund’s performance. Any material revenue upside from the deal could influence MJ’s NAV and attract inflows, given Tilray’s large weighting. ETF investors should monitor changes in Tilray shares as direct indicators of fund value. Shifts in market sentiment toward beverage sector growth could lead to increased ETF trading volumes.

Analysts project that licensing revenue pipelines from branded beer production could partially offset recent declines in Tilray’s cannabis segment. Improved beverage segment cash flows may drive revised revenue estimates for 2027 and beyond. Positive momentum in Tilray’s stock price following the announcement could signal uptrends for MJ ETF holdings. However, investors should consider broader ETF diversification and potential sector rotation risks before reallocating.